Bioactivity:

Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c,

CAS nr:

73030-71-4

Purity:

98%

Molecular Weight:

248,32

SMILES:

CC1=C2C[C@H]3C(=C)CCC[C@]3(C)C[C@]2(O)OC1=O

Formula:

C15H20O3

Pathway:

Apoptosis

Target:

Apoptosis